The PrP-hFUS transgene contains a mouse prion protein promoter directing expression of a hemagglutinin-tagged human wildtype 'fused in sarcoma cDNA' sequence (HA-hFUS). Homozygous PrP-hFUS mice from founder line WT3 (PrP-hFUS-WT3) have FUS overexpression levels that result in an aggressive neurodegenerative phenotype that recapitulates many features of human amyotrophic lateral sclerosis.
Christopher E Shaw, King's College London
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inserted expressed sequence, Humanized sequence) |
The PrP-hFUS transgene expresses a hemagglutinin-tagged human wildtype fused in sarcoma cDNA sequence (HA-hFUS) under the direction of the mouse prion protein (PrP) promoter. The exogenous hFUS protein expressed from the PrP-hFUS transgene has a slightly higher molecular weight than endogenous mouse FUS due to eight additional amino acids and the presence of the HA-tag. The phenotype below describes PrP-hFUS mice from founder line WT3 (PrP-hFUS-WT3).
As expected for the PrP promoter, PrP-hFUS-WT3 mice have HA-hFUS expression levels highest in the brain (cortex), spinal cord and testis; with much lower expression in other tissues. Transgenic mice express exogenous HA-hFUS, as well as endogenous mouse FUS. Compared to nontransgenic mice, the total FUS expression levels are ~1.4-fold greater in hemizygous mice, and ~1.7-fold greater in homozygous mice. Transgene expression of HA-hFUS results in significantly decreased expression of mouse FUS in all transgenic lines (endogenous FUS is downregulated ~0.86-fold in hemizygotes, and ~ 0.62-fold in homozygotes). Mice hemizygous for the PrP-hFUS transgene are viable and fertile with no evidence of significant motor phenotype or pathology. FUS overexpression levels in homozygous mice result in an aggressive neurodegenerative phenotype that recapitulates many features of human amyotrophic lateral sclerosis (ALS). Specifically, homozygous mice exhibit early onset tremor after ~4 weeks of age, followed by globular/granular cytoplasmic FUS inclusions and neuroinflammation of the spinal cord (astroglial [GFAP] and microglial [CD68] reactivity), progressive hind-limb paralysis, and eventually death by ~12 weeks of age. This FUS-ALS phenotype is dependent upon the expression level of the FUS protein, and is associated with a significant shift in FUS localization to the cytoplasm without concomitant loss of FUS from the nucleus. Of note, fluorescent labeling of HA-tagged FUS and ubiquitin in the spinal cord anterior horn reveals FUS inclusions with no ubiquitin staining. Fluorescent labeling of HA-tagged FUS and ubiquitin in the motor cortex shows skein-like cytoplasmic FUS deposits surrounded by ubiquitin; but no co-labelling of the two proteins is evident. These PrP-hFUS mice may be useful in studying neurodegenerative disorders such as ALS and frontotemporal lobar degeneration (FTLD).
The PrP-hFUS transgene was designed to have the mouse prion protein promoter sequences (from vector MoPrp.Xho) and a human wildtype fused in sarcoma cDNA sequence with N-terminal hemagglutinin-tag (HA-hFUS). The ~1.8 kbp transgene was injected into the pronucleus of C57BL/6J oocytes fertilized with Crl:CD1(ICR) sperm. Founder mice were bred to C57BL/6J mice, and a single founder line (WT3) was able to produce transgenic offspring. Transgenic males were bred with C57BL/6J females for at least three additional generations prior to sending to The Jackson Laboratory Repository. Upon arrival, transgenic mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generations to establish our colony.
Expressed Gene | FUS, FUS RNA binding protein, human |
---|---|
Site of Expression |
Allele Name | transgene insertion WT3, Christopher Shaw |
---|---|
Allele Type | Transgenic (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | hFUS; PrP-hFUS line WT3; PrP-hFUS-WT3 |
Gene Symbol and Name | Tg(Prnp-FUS)WT3Cshw, transgene insertion WT3, Christopher Shaw |
Gene Synonym(s) | |
Promoter | Prnp, prion protein, mouse, laboratory |
Expressed Gene | FUS, FUS RNA binding protein, human |
Strain of Origin | (C57BL/6 x Crl:CD1(ICR))F1 |
Chromosome | UN |
Molecular Note | The transgene was designed to have the mouse prion protein promoter sequences (from vector MoPrp.Xho) and a human wild-type Fused in sarcoma (FUS) cDNA sequence with N-terminal hemagglutinin-tag (HA-hFUS). Three founders were established, including line WT3. |
The donating investigator maintained their colony each generation by breeding hemizygous males with wildtype (noncarrier) females from the colony or with C57BL/6J inbred females. They report no problems breeding this way. When maintaining a live colony at The Jackson Laboratory Repository, hemizygous mice may be bred with wildtype (noncarrier) mice from the colony or with C57BL/6J inbred mice (Stock No. 000664).
When using the PrP-hFUS line WT3 mouse strain in a publication, please cite the originating article(s) and include JAX stock #017916 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(Prnp-FUS)WT3Cshw |
Frozen Mouse Embryo | STOCK Tg(Prnp-FUS)WT3Cshw/J | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(Prnp-FUS)WT3Cshw/J | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(Prnp-FUS)WT3Cshw/J | $3373.50 |
Frozen Mouse Embryo | STOCK Tg(Prnp-FUS)WT3Cshw/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.